New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 21, 2014
13:39 EDTMYGNMyriad Genetics rises after court grants U. of Utah motion related to BRCA tests
A court filing in a Utah district court revealed that a judge granted the University of Utah's motion for judicial notice in support of a motion for preliminary injuntive relief in a case against Ambry Genetics. Ambry, the defendant in the case, objected to the University of Utah's characterization that a CMS reduction demonstrated Myriad Genetics' (MYGN) irreparable harm. The suit relates to a Centers for Medicare and Medicaid Services notice of a reimbursement reduction from $2,700 to $1,438.14 for BRCA1 and BRCA2 tests, effective January 1, 2014. Shares of Myriad Genetics are up 2.7% to $37.26 in afternoon trading. Reference Link
News For MYGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 5, 2015
06:15 EDTMYGNMyriad Genetics fights to sustain business model, WSJ reports
Subscribe for More Information
May 4, 2015
09:50 EDTMYGNLeerink to hold next-generation sequencing meeting
Subscribe for More Information
07:12 EDTMYGNAmerican Congress of Obstetrics and Gynecology
2015 ACOG Annual Clinical & Scientific Meeting is being held in San Francisco on May 2-6.
May 3, 2015
17:19 EDTMYGNMyriad Genetics CEO 'actively' searching for acquisitions, WSJ says
In a Wall Street Journal interview, Myriad (MYGN) CEO Mark Capone said the company is currently developing tests for diabetes, autoimmune disorders, and neuropsychiatric conditions, while also "actively looking" for acquisitions. In a separate interview, Robert McDonough, head of Aetna's (AET) clinical policy research, remarked that Myriad should "eventually" be able to have its Vectra DA rheumatoid arthritis test covered by insurance. Reference Link
April 21, 2015
06:40 EDTMYGNStart-up to offer saliva test for breast cancer susceptibility, NY Times says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use